ArticleKidney international reports2024

The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD.

Sophia L Ambruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.